Risk stratification is critical in the care of patients with myelodysplastic syndromes (MDS). Approximately 10% have a complex karyotype (CK), defined as more than two cytogenetic abnormalities, which is a highly adverse prognostic marker. However, CK-MDS can carry a wide range of chromosomal abn...
[quiz 1314, 1330] CrossrefView in ScopusGoogle Scholar [3] E. Torlakovic, E. Skovlund, D.C. Snover, G. Torlakovic, J.M. Nesland Morphologic reappraisal of serrated colorectal polyps Am J Surg Pathol, 27 (2003), pp. 65-81 View in ScopusGoogle Scholar [4] M. Bettington, N. Walke...